Agarwal Arjun
Oruka Therapeutics, Inc. · Senior Vice President
Agarwal Arjun is listed in filings as Senior Vice President at Oruka Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 18, 2026, including sale activity. Recent filings connect the profile to Oruka Therapeutics, Inc. (ORKA). The current snapshot covers public activity from Jan 24, 2025 to May 18, 2026. Reported amounts are shown as $272.3K to $200.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $272k4.6k shares | SellMay 18, 2026 | $59.19 | $86.65 | |
| $244k4.2k shares | SellMay 18, 2026 | $58.34 | $86.65 | |
| $48k800 shares | SellMay 18, 2026 | $60.34 | $86.65 | |
| $43k700 shares | SellMay 18, 2026 | $61.16 | $86.65 |